Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,015 | -40,950 | -31,876 | -23,962 | -12,738 |
| Depreciation Amortization | -83 | 829 | 730 | 449 | 159 |
| Accounts receivable | N/A | -2,042 | N/A | 428 | -600 |
| Accounts payable and accrued liabilities | 549 | -1,050 | 1,108 | 439 | 161 |
| Other Working Capital | -960 | 6,958 | 984 | 1,244 | 28 |
| Other Operating Activity | 2,012 | 17,541 | 10,046 | 7,457 | 4,841 |
| Operating Cash Flow | $-6,497 | $-18,714 | $-19,008 | $-13,945 | $-8,149 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,435 | -6,942 | 24,030 | 24,030 | 18,280 |
| PPE Investments | -15 | -88 | -88 | -88 | -51 |
| Investing Cash Flow | $-2,450 | $-7,030 | $23,942 | $23,942 | $18,229 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -20,722 | -11,250 | -7,500 | -3,750 |
| Common Stock Issued | 5 | 61,081 | 6,736 | 3,988 | 42 |
| Other Financing Activity | -32 | -59 | -38 | -31 | -23 |
| Financing Cash Flow | $-27 | $40,300 | $-4,552 | $-3,543 | $-3,731 |
| Beginning Cash Position | 18,818 | 4,262 | 4,262 | 4,262 | 4,262 |
| End Cash Position | 9,844 | 18,818 | 4,644 | 10,716 | 10,611 |
| Net Cash Flow | $-8,974 | $14,556 | $382 | $6,454 | $6,349 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,497 | -18,714 | -19,008 | -13,945 | -8,149 |
| Capital Expenditure | -15 | -88 | -88 | -88 | -51 |
| Free Cash Flow | -6,512 | -18,802 | -19,096 | -14,033 | -8,200 |